Hepatic Cell News Volume 6.05 | Feb 11 2022

    0
    16







    2022-02-11 | HCN 6.05


    Hepatic Cell News by STEMCELL Technologies
    Vol. 6.05 – 11 February, 2022
    TOP STORY

    Ionizable Liposomal siRNA Therapeutics Enables Potent and Persistent Treatment of Hepatitis B

    A novel ionizable lipidoid nanoparticle and a state-of-the-art lyophilization technology were developed, enabling to deliver small interfering RNA (siRNA) targeting apolipoprotein B into the hepatocytes with an ED50 of 0.05 mg/kg after intravenous injection.
    [Signal Transduction and Targeted Therapy]

    Full Article

    Microscopy images of pluripotent stem cells (PSCs) and PSC-derived cells for the #StemCellfie contest.
    PUBLICATIONSRanked by the impact factor of the journal

    Caffeine Blocks SREBP2-Induced Hepatic PCSK9 Expression to Enhance LDLR-Mediated Cholesterol Clearance

    Following the observation that caffeine (CF) reduced circulating PCSK9 levels and increased hepatic low-density lipoprotein receptor (LDLR) expression, additional CF-derived analogs with increased potency for PCSK9 inhibition compared to CF itself were developed.
    [Nature Communications]

    Full ArticlePress Release

    Small Molecule SWELL1 Complex Induction Improves Glycemic Control and Nonalcoholic Fatty Liver Disease in Murine Type 2 Diabetes

    The authors showed that ICl,SWELL and SWELL1 protein were reduced in adipose and β-cells in murine and human diabetes.
    [Nature Communications]

    Full Article

    PET-Based Radiogenomics Supports mTOR Pathway Targeting for Hepatocellular Carcinoma

    Scientists explored the genomic and molecular underpinnings of HCC with increased fluorine-18 fluorodeoxyglucose uptake in positron emission tomography (PET) and identified therapeutic targets based on this imaging-genomic surrogate.
    [Clinical Cancer Research]

    Abstract

    Temporal Analyses of Postnatal Liver Development and Maturation by Single-Cell Transcriptomics

    Researchers observed unexpectedly high levels of hepatocyte heterogeneity in the developing liver and the progressive construction of the zonated metabolic functions from pericentral to periportal hepatocytes, which was orchestrated with the development of sinusoid endothelial, stellate, and Kupffer cells.
    [Developmental Cell]

    AbstractGraphical Abstract

    PD-L1 Promotes Myofibroblastic Activation of Hepatic Stellate Cells by Distinct Mechanisms Selective for TGF-β Receptor I versus II

    To determine the role of programmed death-ligand 1 (PD-L1) in myofibroblastic activation of hepatic stellate cells (HSCs), investigators disrupted PD-L1 of HSCs by shRNA or anti-PD-L1 antibody.
    [Cell Reports]

    Full ArticleGraphical Abstract

    DDR1 Promotes Hepatocellular Carcinoma Metastasis through Recruiting PSD4 to ARF6

    Researchers found that discoidin domain receptor 1 (DDR1) was upregulated in HCC tissues, and the expression of DDR1 in TNM stage II-IV was higher than that in TNM stage I in HCC tissues, and high DDR1 expression was associated with poor prognosis.
    [Oncogene]

    Full Article

    PBLD Inhibits Angiogenesis via Impeding VEGF/VEGFR2-Mediated Microenvironmental Cross-Talk between HCC Cells and Endothelial Cells

    Phenazine biosynthesis-like domain-containing protein (PBLD) exerted an inhibitory effect on angiogenesis not only via blocking the VEGFR2 expression in endothelial cells, but also through downregulating HIF-1a-induced VEGF expression and secretion in hepatocellular carcinoma cells.
    [Oncogene]

    Full Article

    HBx Increases Chromatin Accessibility and ETV4 Expression to Regulate Dishevelled-2 and Promote HCC Progression

    Investigators confirmed that ETV4 was significantly upregulated by Hepatitis B virus X protein (HBx) and involved in super-enhancer-associated chromatin accessibility. Increased expression of ETV4 promoted HCC cell invasion and metastasis by upregulating DVL2.
    [Cell Death & Disease]

    Full Article

    Stat4 rs7574865 Polymorphism Promotes the Occurrence and Progression of Hepatocellular Carcinoma via the Stat4/CYP2E1/FGL2 Pathway

    Scientists reported the mechanism by which signal transducer and activator of transcription 4 (stat4) rs7574865 promoted the occurrence and progression of HCC.
    [Cell Death & Disease]

    Full Article

    MEHP Promotes Liver Fibrosis by Down-Regulating STAT5A in BRL-3A Hepatocytes

    The authors demonstrated that mono-2-ethylhexyl phthalate (MEHP) exposure inhibited the expression of STAT5A by causing oxidative damage in BRL-3A hepatocytes, thus accelerating the expression of key molecules in fibrosis and promoting the occurrence of liver fibrosis.
    [Chemosphere]

    AbstractGraphical Abstract

    Tumor Microenvironment Acidity Triggers Lipid Accumulation in Liver Cancer via SCD1 Activation

    Investigators revealed that acidosis could significantly trigger fatty acid synthesis to promote liver tumorigenesis by upregulating SCD1 in a PI3K/AKT activation dependent manner and simultaneously promote SCD1 binding to PPARα.
    [Molecular Cancer Research]

    Abstract

    Non-Invasive Detection and Complementary Diagnostic of Liver Metastases via Chemokine Receptor 4 Imaging

    Researchers observed the elevated expression of chemokine receptor 4 (CXCR4) in uveal melanoma (UM) patient liver tissues, and high CXCR4 expression in liver metastases of UM murine models, regardless of the expression levels in the primary tumors.
    [Cancer Gene Therapy]

    Full Article

    New human primary cancer-sourced blood products, immune cell subsets, and more. Click to view products.
    REVIEWS

    Cigarette Smoking and Liver Diseases

    Investigators discuss the relevance of promoting smoking cessation to improve rates of treatment response in clinical trials, fibrosis regression, risk of hepatocellular carcinoma, and liver transplant outcomes.
    [Journal of Hepatology]

    Full Article

    The Altered Lipidome of Hepatocellular Carcinoma

    Scientists summarize the current trends and findings of the altered lipidomic landscape of HCC and discuss their potential biological significance for hepatocarcinogenesis.
    [Seminars in Cancer Biology]

    Full Article

    The Role of Exosomal miRNA in Nonalcoholic Fatty Liver Disease

    The authors discuss current knowledge about the biogenesis of exosomal miRNA and exosome-mediated microRNA transfer and review the potential of exosomal miRNA in diagnosis and therapeutics of nonalcoholic fatty liver disease.
    [Journal of Cellular Physiology]

    Abstract

    INDUSTRY AND POLICY NEWS

    Kelly Stevens Receives $1.3M Allen Distinguished Investigator Award to Study How Liver Develops

    University of Washington bioengineer Kelly Stevens, whose research focuses on mapping human organs and engineering artificial human tissues, has received an Allen Distinguished Investigator Award to support her work to map and understand how human livers develop.
    [University of Washington Department of Bioengineering]

    Press Release

    FEATURED EVENT

    EMBO: Microbial Infections and Human Cancer

    April 6 – 9, 2022
    Heidelberg, Germany

    > See All Events

    JOB OPPORTUNITIES

    Postdoctoral Research Scientist – Immune Regulation

    Columbia University – New York, New York, United States

    Postdoctoral Positions – Translational 3D Pathology

    University of Washington – Seattle, Washington, United States

    Postdoctoral Researcher – 3D Advanced Microscopy

    IRB Barcelona – Barcelona, Spain

    Postdoctoral Research Fellow – Tumor Metabolism

    Wayne State University School of Medicine – Detroit, Michigan, United States

    Postdoctoral Research Fellow – Lipid Droplet Biology in Liver Function

    Mayo Clinic – Rochester, Minnesota, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Hepatic Cell News Twitter